The role of peripheral blood microRNAs as biomarkers of Alzheimer’s disease

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

To investigate the role of microRNAs as biomarkers for Alzheimer's disease (AD) to allow for early diagnosis prior to the onset of clinically apparent memory decline. MicroRNA expression levels in blood samples from patients with AD, mild cognitive impairment and normal cognition will be assessed in order to determine potential biomarker candidates.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2018

Funding Scheme: Postgraduate Scholarships

Funding Amount: $83,284.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epigenetics (incl. Genome Methylation and Epigenomics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Alzheimer disease | biomarkers | dementia | epigenetics | microrna